MUC1突变所致常染色体显性小管间质性肾病
本文报告一例有慢性肾脏病家族史的西班牙裔患者,基因检测发现MUC1基因VNTR区域7个胞嘧啶中插入1个胞嘧啶的突变,确诊为MUC1肾病(旧称髓质囊性肾病1型),属常染色体显性小管间质性肾病。该病表现为显性遗传、尿沉渣无异常、无或轻度蛋白尿及肾功能进行性下降,基因检测可用于家族遗传咨询和密切监测疾病进展。
要点
- MUC1肾病为常染色体显性小管间质性肾病,表现为尿沉渣无异常、无或轻度蛋白尿及肾功能进行性下降。
- 检测MUC1基因VNTR区域7个胞嘧啶中插入1个胞嘧啶的突变可用于确诊。
- 确诊后可为受累家族提供遗传咨询并密切监测疾病进展。
核心结论
- MUC1肾病是常染色体显性小管间质性肾病的一种,基因检测可发现MUC1基因VNTR区域7个胞嘧啶中插入1个胞嘧啶的突变,从而确诊并为家族提供遗传咨询和密切监测。
研究设计与样本
- 本文为病例报告,报告一例有慢性肾脏病家族史的西班牙裔患者,基因检测MUC1突变阳性。
主要发现
- 该患者有慢性肾脏病家族史,MUC1突变检测阳性。
- 常染色体显性小管间质性肾病共同临床表现为显性遗传、尿沉渣无异常、无或轻度蛋白尿及肾功能进行性下降。
关键数值与推荐
- KDIGO 2014年共识报告提出常染色体显性小管间质性肾病的命名。
- MUC1肾病最著名的突变为MUC1基因VNTR区域7个胞嘧啶中插入1个胞嘧啶。
临床怎么用
- 对疑似常染色体显性小管间质性肾病患者可检测MUC1基因VNTR区域7个胞嘧啶中插入1个胞嘧啶的突变以确诊。
- 确诊后可为受累家族提供遗传咨询,并密切监测肾功能进展。
局限性
- 本文为单例病例报告,MUC1肾病的病理生理机制仍在研究中。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Mucin 1 kidney disease, previously referred to as medullary cystic kidney disease type 1, is a rare hereditary kidney disease. It is one of several diseases now termed autosomal dominant tubulointerstitial kidney disease, as proposed by a KDIGO (Kidney Disease: Improving Global Outcomes) consensus report in 2014. Autosomal dominant tubulointerstitial kidney diseases share common clinical findings, such as autosomal dominant inheritance, bland urinary sediment, absent to mild proteinuria, and progressive loss of kidney function. Although the pathophysiology of mucin 1 kidney disease is still under investigation, genetic testing has been developed to detect the most well-known mutation, a single cytosine insertion into a string of 7 cytosines in the variable-number tandem repeat (VNTR) region of the MUC-1 gene. With this diagnostic tool, nephrologists can offer genetic counseling to affected families and monitor closely for progression of disease. We report a Hispanic patient with a strong family history of chronic kidney disease who tested positive for the MUC1 mutation.
引用
- Yu SM, Bleyer AJ, Anis K, et al. Autosomal Dominant Tubulointerstitial Kidney Disease Due to MUC1 Mutation. Am J Kidney Dis. 2017. PMID: 29217307. doi:10.1053/j.ajkd.2017.08.024
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。